OnKure Therapeutics (OKUR) Amortizatization of Intangibles (2020 - 2024)
OnKure Therapeutics' (OKUR) quarterly Amortizatization of Intangibles came in at $260000.0 in Q3 2024, down 83.12% YoY from $1.5 million in Q4 2023, and down 64.77% on a QoQ basis from $738000.0 in Q2 2024.
OnKure Therapeutics (OKUR) Amortizatization of Intangibles (2020 - 2024) Analysis & Trends
OnKure Therapeutics (OKUR) has 5 years of Amortizatization of Intangibles data on file, last reported at $260000.0 in Q3 2024.
- Quarterly Amortizatization of Intangibles fell 83.12% year-over-year to $260000.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $3.1 million (down 25.46% YoY) and the FY2023 annual result came in at $4.8 million, up 484.7% from the prior year.
- Amortizatization of Intangibles fell to $260000.0 in Q3 2024, from $738000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $1.5 million in Q3 2023 to a low of -$89000.0 in Q4 2021.
- A 5-year average of $459125.0 and a median of $203500.0 in 2022 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2021 — Amortizatization of Intangibles slumped 8100.0% — and 2023, when it soared 77100.0%.
- Tracing OKUR's Amortizatization of Intangibles over 5 years: stood at $1000.0 in 2020, then plunged by 9000.0% to -$89000.0 in 2021, then jumped by 828.09% to $648000.0 in 2022, then surged by 89.2% to $1.2 million in 2023, then slumped by 78.79% to $260000.0 in 2024.
- The last three Amortizatization of Intangibles figures came in at $260000.0 (Q3 2024), $738000.0 (Q2 2024), and $906000.0 (Q1 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | OnKure Therapeutics | 195.74 Mn | 19.35 Mn | - | 101,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 260,000.00 |
| Sep 30, 2024 | 260,000.00 |
| Jun 30, 2024 | 738,000.00 |
| Jun 30, 2024 | 738,000.00 |
| Mar 31, 2024 | 906,000.00 |
| Mar 31, 2024 | 906,000.00 |
| Dec 31, 2023 | 1.23 Mn |
| Dec 31, 2023 | 1.23 Mn |
| Sep 30, 2023 | 1.54 Mn |
| Sep 30, 2023 | 1.54 Mn |
| Jun 30, 2023 | 1.24 Mn |
| Jun 30, 2023 | 1.24 Mn |
| Mar 31, 2023 | 770,000.00 |
| Mar 31, 2023 | 770,000.00 |
| Dec 31, 2022 | 648,000.00 |
| Dec 31, 2022 | 648,000.00 |
| Sep 30, 2022 | 147,000.00 |
| Sep 30, 2022 | 147,000.00 |
| Jun 30, 2022 | 23,000.00 |
| Jun 30, 2022 | 23,000.00 |